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Abstract
The objective of this study was to determine the sustained economic impact of a health promotion/disease
prevention program delivered through a large regional health plan. This was a retrospective analysis of health
risk, health claims, and cost using a mixed model factorial design for the years 2002–2009 that compared
program participants to nonparticipants. All analyses were adjusted for age, sex, morbidity, and baseline health
care costs as appropriate. The findings presented herein indicate a positive return on investment (ROI) for each
program year with ratios ranging from a low of 1.16:1 to a high of 2.83:1. The average ROI collapsed across all 8
years was 2.02:1. The 2009 ROI approximated over $6 million in total savings. This study demonstrates the
sustained economic value of a comprehensive health promotion program. (Population Health Management
2014;17:90–99)
Introduction
The rise of health care costs represents a significantthreat to economic competitiveness, not to mention the
health and well-being of the workforce and the population at
large. In recent years industry discussions have shifted from a
fixation on the disease management of high-cost chronic
conditions to full-spectrum programs. Addressing the entire
population and health continuum is now referred to as
‘‘population health.’’ To date, few population health-oriented
programs and approaches have demonstrated the viability of
meaningful impact on population-level health profiles in an
economically sustainable manner over extended time periods.
An evidence base is building around population health that
demonstrates the effectiveness of some programs to favorably
improve the risk and cost profiles of large populations,1–13
and 3 separate reviews of this literature have concluded that
such programming can produce a favorable return on in-
vestment (ROI) and positively impact the risk profile at a
population level.14–16 However, the preponderance of these
studies have taken a relatively short view of the available data
leaving long-term sustainability in question.17 Recent excep-
tions to the relative paucity of longitudinal data include work
published by Neville, Merrill, and Kumpfer, which showed
some promise with regard to favorable risk profiles over an 8-
year period,18 as well as work by Byrne and colleagues,19
neither of which examined financial outcomes specifically.
The escalating costs associated with health are currently
being assumed in large part by employers and insurers (with
increasing costs shifting to the consumer and practitioners).
This pressure has fostered the growth of the health and
wellness industry as an increasingly ubiquitous strategy to
improve the health of large populations and concurrently
slow the increasing rate of associated costs. In fact, health
and wellness programs have become a central business
strategy for many progressive employers and health plans.
Program elements range widely from community-based ef-
forts20 to disease-specific models,21,22 and comprehensive
continuum of health approaches,23 all delivered through
various technological and interpersonal channels.
In the current literature, the economic value of individual
programs is usually ascertained retrospectively after a period
of 4 years or less.10,12,13,24 This is typically because of the
difficulties of maintaining a longitudinal database on a
population cohort, cohort attrition, ongoing changes in pro-
gramming characteristics, and the limits of the randomized
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trial design, including but not limited to the complexities
of creating comparative groups. This begs the question—
although a wide range of organizations and the general
public may benefit from health and wellness programming
clinically and financially25—of whether the benefit is sus-
tainable and for how long.
This study reports on a longitudinal set of wellness and
disease prevention program evaluations focusing on eco-
nomic sustainability. The program is an established health
and disease prevention program provided through a large
insurer over an 8-year period. The current paper specifically
addresses the longitudinal economic value of such a pro-
gram with a specific emphasis on the following longitudinal
questions:
 Who are program participants? How do they differ from
nonparticipants?
 What are the estimated economic/cost benefits and ROI
of the program over time? How does participant utili-
zation and cost compare with that of nonparticipants?
 Is there a relationship between cost, utilization, and
degree of program engagement?
Methods
The program
The health and wellness program evaluated was a com-
prehensive health promotion and disease prevention pro-
gram. The program was provided by an independent health
plan to its members as part of a variety of programs, services,
and support to improve the health and well-being of its
members. This health plan includes health maintenance or-
ganization, preferred provider organization, and consumer-
directed health plan products. Health risk assessments
(HRAs) were completed by participants, and followed by
biometric screening (ie, blood pressure, total cholesterol, li-
pid subfractions, glucose, body composition indices of
height, weight, body mass index [BMI], waist circumference,
percentage of body fat) and lifestyle intervention compo-
nents. Other screenings may have been recommended based
on sex, age, and risk profile (eg, pap smear, bone density,
sigmoidoscopy).
Participants also underwent a counseling session with a
health care professional to review their biometric values,
identify their particular risks, discuss wellness goals, and
develop a behavior change action plan. Counseling sessions
were offered in several formats including individual, group,
face-to-face, and telephonic. Tailored, online digital health
coaching intervention programs were provided to partici-
pants that focused on weight management, nutrition man-
agement, smoking cessation, and stress management. These
digital health coaching programs were designed as behav-
ioral health interventions to aid participants to create and
reach health-promoting goals for the purpose of changing
lifestyle-related behaviors. These online programs were not
available to participants during the first 2 years of the pro-
gram as evaluated here.
The sample
Data presented in Table 1 show the sample sizes for all
eligible plan members and program participants by year
over the 8-year evaluation period. The relative trend shows a
steady increase in the number of plan members from 2002 to
2009. There was a concomitant decline in the rate of partic-
ipation (8.1% to 3.9%) when considered as the percent of
eligible. A total of 2124 unique participants used the online
digital health coaching programs from 2004 to 2009. Of those
who utilized these programs, about 44% of participants used
the weight management program, followed by 35% who
used the nutrition management program, 18% who used the
stress management program, and 3% who used the smoking
cessation program. The actual gross number of participants
over the 8-year term fluctuated with no clear trends. In-
centives may have been used with some plan customers in
some years but the details of such program elements were
unavailable for consideration in any analyses.
Because there is an inherent self-selection bias with non-
randomized participation in wellness programs, interpreta-
tion of program outcomes relative to nonparticipants must
take this biasing into account. For all between-cohort analyses
a subset of nonparticipants were matched to participants us-
ing the propensity score matching method, followed by chi-
square and t tests, which assured no significant differences in
the characteristics of participants and matched nonpartici-
pants. The propensity score matching method is a widely
used statistical matching method in observed studies. It gen-
erates the predicted probability that an individual receives the
treatment of interest from 1 or many confounding variables.
For each participant the procedure seeks a nonparticipant
with the same or nearly the same estimated probability of
inclusion in the treatment, in order to minimize the distance
between matched cases on those confounding variables.26–29
Table 1. Sample Size by Participation
Status and Year
Total Sample Size
Participation
N % of total
2002 189,724 15,328 8.1%
2003 200,609 13,936 6.9%
2004 212,945 14,878 7.0%
HRA#1 N= 10,215 4.8%
HRA#2 N = 4,962 2.3%
2005 224,609 16,555 7.4%
2006 325,801 18,903 5.8%
2007 329,707 16,726 5.1%
2008 340,118 15,239 4.5%
2009 336,515 13,243 3.9%
Total 457,371 57,940 12.7%
Yearly Wellness Program 1,211 0.3%
Notes:
(1) In 2004 the organization changed health risk assessments
(HRAs). Differences in constructs and scales are noted where
relevant. There is an overlap of 299 people between the 2 versions
of the HRA.
(2) Yearly Wellness Program represents the total and percentage of
individuals who participated in all 8 years evaluated within this
manuscript.
(3) In some cases the constructs in the 2 different HRA instruments
are incompatible or absent, which limits some comparisons from one
year to another.
(4) This table reflects the total sample of the participation in the
study. The number does not reconcile with most of the analyses in
the manuscript because of filtrations and subpopulations that were
studied in each section.
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Each year a subsample of nonparticipants was one-to-one
matched to participants on sex, age, morbidity score, and total
health care costs in the pre-participation year(s); no significant
difference was found between participants and nonpartici-
pants after matching (P> .05). These matching variables also
were set as covariates in the cost comparisons to better reveal
the impact of the program.
Demographic data on sex and age of participants and
nonparticipants are included in Table 2. These data suggest
that women were more likely to participate in the program
relative to men in 2009, but this was consistent with the
gender distribution in the eligible membership as a whole.
This trend was consistent in years 2006–2009 but somewhat
reversed from the more even gender split in years 2002–2005.
This change may be related, in part, to worksite recruitment
efforts or change in benefits structure initiated between 2005
and 2006. Program participants also were significantly
older than their 2009 nonparticipating counterparts (a find-
ing consistent over all 8 years of data). The mean ages
for participation across all years ranged from 51.6 to 53.8
years old.
Comorbidity scores
All subjects (participants and nonparticipants) were as-
sessed using the Johns Hopkins Adjusted Clinical Groups
Case-Mix System.30 The scale measures aggregate morbidity
levels ranging from 0–5 where a score of 0 indicates no illness
or morbidity and a score of 5 indicates severe illness burden
or maximum level of morbidity. For every year of the pro-
gram, participants received higher morbidity scores relative
to nonparticipants, suggesting that the program was used by
individuals with significant disease burden. For all age ran-
ges there were 42 instances of unadjusted statistical signifi-
cance, which showed that program participants had higher
levels of morbidity (Table 3).
Measures
Program participants were required to complete an HRA
at program entry. Biometric measures were collected by
various members of the staff, and included cholesterol and
related subfractions (ie, high-density lipoprotein cholesterol,
low-density lipoprotein cholesterol, triglycerides), fasting
blood glucose, systolic and diastolic blood pressure, BMI,
and waist circumference using standard clinical protocols.
Utilization and cost measures consisted of total health care
expenditures, and expenditures were categorized by inpa-
tient costs, number of inpatient admissions, length of stay
(LOS) per admission, outpatient cost/claims, medical ser-
vices, and pharmacy. Data are expressed in unadjusted
dollars and utilization counts except where noted.
Results
Health care claims and costs
Table 4 examines 2009 health care costs and utilization
among program participants versus nonparticipants. The
data indicate that 2009 program participants had signifi-
cantly lower total health care costs and costs by category
with the exception of medical costs relative to nonpartici-
pants. These medical costs include professional services (eg,
office visits), laboratory, radiology, surgery/anesthesia, and
other facility outpatient and miscellaneous services. Out-
patient costs include outpatient surgeries, emergency room,
mental health partial-day services, and diagnostic and
treatment services. The outpatient costs reflect the facility
portion of the encounter exclusive of professional services (ie,
medical costs). The proportion of program participants
having made any claim in 2009 was higher in total and
within the medical claim category. However, nonpartici-
pants were more likely to have made more claims in the
cost categories of inpatient and pharmacy claims relative to
participants. The average number of hospital admissions,
total inpatient days, and average LOS per admission also
were significantly higher for nonparticipants relative to
participants.
Return on investment
Net savings were calculated by determining the difference
between total health care costs for the nonparticipating co-
hort and the participating cohort after subtracting the pro-
gram expenses from the actual health care cost savings by
year for participants. Program expenses included staff sal-
aries, employee benefits, employer taxes, state general excise
taxes, medical supplies, office supplies and printing, postage
and freight, utilities and telephone, furniture and equipment
expense, occupancy expenses, professional services, adver-
tising and promotions, insurance, travel, depreciation and
amortization, data processing and software purchases, and
Table 2. Program Participant Demographic Data 2002–2009
Sample Size
2002 2003 2004 2005 2006 2007 2008 2009
N = 15,328 N = 13,936 N = 14,878 N = 16,555 N = 18,903 N = 16,726 N= 15,239 N= 13,243
Sex
Male 43.6% 43.1% 41.9% 41.7% 36.6% 35.3% 34.3% 33.6%
Female 56.4% 56.9% 58.1% 58.3% 63.4% 64.7% 65.7% 66.4%
Age Distribution
18–29 3.4% 3.4% 4.0% 4.9% 6.3% 6.2% 6.1% 5.4%
30–39 11.6% 10.5% 10.7% 11.4% 13.8% 14.2% 13.3% 13.1%
40–49 25.1% 24.2% 23.8% 23.1% 23.1% 22.8% 22.4% 21.3%
50–59 30.7% 30.6% 31.3% 31.3% 28.8% 28.7% 28.0% 28.0%
60–69 15.9% 17.7% 17.6% 17.6% 18.0% 18.3% 19.3% 20.4%
70 + 13.4% 13.6% 12.6% 11.7% 10.0% 9.8% 11.0% 11.7%
Mean Age 53.2 53.8 53.3 52.8 51.6 51.6 52.3 52.9
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general administrative expenses (human resources, legal,
accounting, and administrative services). These expenses are
displayed by year in Table 5.
Table 6 presents an ROI estimate for 2009 by analyzing the
costs of wellness program members who did not use the
program initially (2002–2008), but who then became partic-
ipants in 2009, relative to matched nonparticipants who
never used the program during the 8 years. A subsample of
nonparticipants was matched to participants on sex, age,
morbidity score, and total health care costs in the previous 3
years (2006–2008) and no significant difference was found
between participants and nonparticipants after matching
Table 3. Morbidity Levels by Age Stratification and Participation Year
2002 2003 2004 2005
Nonparticipants Participants Nonparticipants Participants Nonparticipants Participants Nonparticipants Participants
18–29 1.24 1.46 1.26 1.57 1.27 1.57 1.30 1.57
30–39 1.50 1.69 1.51 1.67 1.51 1.74 1.52 1.70
40–49 1.84 2.00 1.87 2.03 1.87 2.01 1.89 2.07
50–59 2.22 2.35 2.25 2.37 2.27 2.41 2.29 2.45
60–69 2.62 2.76 2.65 2.79 2.67 2.81 2.70 2.82
70 + 3.12 3.17 3.15 3.25 3.18 3.30 3.27 3.34
Overall 2.11 2.33 2.16 2.38 2.18 2.39 2.21 2.40
2006 2007 2008 2009
Nonparticipants Participants Nonparticipants Participants Nonparticipants Participants Nonparticipants Participants
18–29 1.66 1.80 1.66 1.86 1.72 1.91 1.84 2.05
30–39 1.90 1.97 1.89 1.98 1.95 2.05 2.07 2.18
40–49 2.14 2.16 2.14 2.14 2.20 2.25 2.34 2.40
50–59 2.48 2.54 2.47 2.53 2.55 2.59 2.70 2.76
60–69 2.85 2.93 2.84 2.90 2.89 2.98 3.02 3.10
70 + 3.45 3.44 3.49 3.47 3.51 3.49 3.57 3.56
Overall 2.36 2.49 2.37 2.49 2.43 2.58 2.57 2.73
Note: Morbidity levels are calculated for program participants and nonparticipants based on their status in the given year. Italicized text
indicates a statistically significant difference between morbidity levels for each age group and overall for participants and nonparticipants for
each year, P< 0.05.
Table 4. 2009 Program Participants vs. Nonparticipants on Health Care Costs and Claims
2009
Participant
2009
Nonparticipant Trend (Participant vs.
Nonparticipant)Sample Size N = 13,243 N= 299,096
2009 health care costs
Total costs $2,426 $2,725 P < 0.005
Inpatient $298 $509 P < 0.005
Outpatient $299 $318 P = 0.028
Medical $1,384 $1,306 P < 0.005
Rx (prescriptions) $444 $592 P < 0.005
2009 health care claims
Making any claim (%) 95.7% 88.5% P < 0.005
Inpatient 2.6% 4.3% P < 0.005
Outpatient 20.4% 20.8% P = 0.281
Medical 94.9% 86.9% P < 0.005
Rx 53.5% 54.5% P = 0.016
2009 reported service counts (per 1000 members)
Average number of service counts 36,754 35,313 P = 0.001
Inpatient 31 53 P < 0.005
Outpatient 432 428 P = 0.134
Medical 28,530 24,765 P < 0.005
Rx 7,761 10,067 P < 0.005
2009 average inpatient days (per 1000 members) 130 260 P < 0.005
2009 average Length of Stay per admission
(for participants with at least one hospital
admission, per 1000 members)
3,652 4,409 P < 0.005
Note: The comparison of 2009 total health care costs is derived from the data on those with and without claims; nonparticipants in 2009
have not participated in the wellness program in any of the 8 years.
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(P > .20). These matching variables also were set as covariates
in the cost comparisons to better reveal the impact of the
program. After matching and adjusting, the total costs in
2009 were estimated to be $3422 for nonparticipants and
$2870 for participants, which generated a projected savings
of $522 per participant. The net savings per participant was
$264 after excluding the program cost. Total 2009 net savings
based on this estimate was calculated at over $6 million.
Figure 1 displays the ROI by program year after statistically
matching and adjusting for sex, age, baseline morbidity level,
and baseline health care costs.1 Matching variables included
sex, age, morbidity score, and total health care costs in the
previous 3 years prior to the index year (ie, a rolling 3-year
matching window). The years 2002–2004 were matched by
previous years that had available data. The figure indicates a
positive ROI for each program year ranging from a low of
1.16:1 to a high of 2.83:1 with an average ROI across all 8 years
of data of 2.02:1.
Cost and participation
The research team also examined the association between
program participation and health care costs before and after
utilizing the program within the same cohort. This was done
by analyzing the claims trend for program members who
initially did not use the program services in 2002 through
2007 (a 6-year cost ‘‘run-in’’ period) and then began partici-
pating in the index year of 2008 relative to a propensity score
matched cohort of nonparticipants (matched one-to-one on
sex, age, morbidity in 2006, and total health care cost in 2006)
who never participated in the program from 2002 to 2009.
The matching strategy yielded successful matches (ie, non-
significant group differences for these variables, P > .40). Sex,
age, and morbidity in 2006 also were used as covariates in
the model to better equate the 2 groups. The trajectory de-
picted in Figure 2 suggests participants maintained an es-
sentially flat cost trend (Zero Trend)31 following program
participation in 2008 while nonparticipants showed a sig-
nificant and escalating increase on total costs year over year.
In order to further examine the program’s cost impact
based on level of engagement, the following analyses were
based on the consistency of program participation oper-
ationalized as the total number of years a plan member
participated in the program relative to total 2009 costs. Fig-
ures 3 and 4 present these data for all 2002–2009 members
and for members who made 1 or more claims in 2009, re-
spectively. In both cases the analyses demonstrate a strong
linear association between the number of program partici-
pation years and lower total health care costs in 2009.
Finally, the research team decided to examine the relative
value of engagement (ie, number of years of program par-
ticipation) relative to morbidity values as measured by the
Johns Hopkins Adjusted Clinical Groups Case-Mix System.
Figure 5 plots average 2009 costs by morbidity values. The
graph indicates greater spread with increased morbidity
suggesting greater direct ROI as an interaction between
baseline morbidity and degree of long-term engagement. The
actual dollar values are presented in Table 7.
Discussion
The traditional medical establishment, with its effective
emphasis on acute care, cannot be expected to solve the
health care crisis alone. Nor will the evidence base for pop-
ulation health programming be built through the conduct of
traditional randomized clinical trials.32 However, an evi-
dence base must be built nonetheless and such evidence
certainly should include real-world demonstration of the
sustainability of population health programming. As part of
a logic map (Figure 6) that guides the development of a
leading and lagging indicator framework, such evidence
should address participation, behavior change, risk modifi-
cation and economic outcomes. This study sought to con-
tribute to building that evidence base by examining 8 years
of economic and utilization data in a cohort of program
participants and a matched set of nonparticipants. The
findings here do not and are not intended to provide a
comprehensive evaluation of each proof point in the map but
rather to begin to fill in puzzle pieces of and support for
portions of this logic map.
This study posed several questions of these data. Who are
program participants? How do they differ from nonparticipants?
Participants tended to be female; a finding consistent with a
robust literature that supports the notion that women are
more active consumers of health information.33 Importantly,
there are reasons to believe that gender-specific messaging
may help with the participation of both sexes. Participants
also tended to be older. However, given the power of the test
in large samples such as those used here and the small mean
arc differences, it is unlikely that this finding has meaningful
Table 5. Program Costs per Participant
Program Costs
Number of
Participants
Costs per
Participant
2002 $4,128,000 20,247 $204
2003 $4,250,000 19,442 $219
2004 $4,972,000 21,071 $236
2005 $5,004,000 23,352 $214
2006 $5,867,966 26,861 $218
2007 $5,784,864 24,494 $236
2008 $6,831,683 24,064 $284
2009 $6,671,203 23,142 $288
Table 6. 2009 Estimated Costs and ROI
from Trend Analysis
Health
Care
Costs
HP
Program
Costs
Total Costs
2009
Nonparticipants
(n = 2161)
$3,422 $3,422
Participants
(n = 2161)
$2,870 $288 $3,158
Net Savings/
Participant
$264
X Participants # 23,142
= Total Net
Savings
$6,109,488
2009 ROI = $Savings/$Costs= $552/$288= $1.92:$1. The estimated
net savings in 2002–2008 years are not presented here but are avail-
able from the author by request. HP, health plan; ROI, return on
investment.
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implications for how one might develop and/or implement
program elements.
For every evaluation year of the program, participants
received higher morbidity scores relative to nonparticipants,
suggesting that the program was used by individuals with
significant need. This runs contrary to the common argument
that the ‘‘worried well’’ are overrepresented as participants
in wellness programs. However, this finding is consistent
with what is known about illness behavior34 and the health
belief model.35 In other words, signs, symptoms, and re-
duced functionality often serve as motivators for seeking
information, skills, treatment, and, ultimately, relief from the
consequences of reduced health.
The research team also wanted to ask a couple of related
questions such as What are the estimated economic/cost benefits
and ROI of the program over time? How does participant utili-
zation and cost compare with that of nonparticipants?
The findings presented here indicate a positive ROI for
each program year with ratios ranging from a low of 1.16:1 to
a high of 2.83:1. The average ROI collapsed across all 8 years
was 2.02:1. The 2009 ROI approximated over $6 million in
total savings. Further, data indicated that for a secondary
cohort there was a strong positive change in health care ex-
penditures (ie, bending the trend)30 associated with the index
year of participation relative to a ‘‘never participated’’ mat-
ched comparison cohort. The pattern of utilization also was
different for the 2 cohorts. Participants were more likely to
make a claim in any given year but nonparticipants had a
disproportionate pattern of utilization in the cost categories
of hospital admissions, average LOS, total annual inpatient
days, and pharmacy. When one considers the overhead
program costs that were included in the program cost ad-
justments (ie, salaries, benefits, employer taxes, state excise
taxes, medical supplies, office supplies, printing, postage and
freight, utilities and telephone, furniture and equipment ex-
pense, occupancy expenses, professional services, advertis-
ing/promotion, insurance, travel, depreciation and
amortization, data processing, software purchases, general
FIG. 1. Return on investment (ROI) by program year.
FIG. 2. Total costs comparison
between those who never partici-
pated in the program and those who
started the program in 2008 and
continued it in 2009. Note: Total
health care costs include inpatient,
outpatient, medical, and pharmacy
costs. Members who had conflicting
sex in multiple data sets, who re-
ported being pregnant, or more than
365 total inpatient days in any 1 year
were excluded. Participants and
nonparticipants were matched on
sex, age, morbidity in 2006, and total
health care cost in 2006. Savings also
were adjusted for sex, age, and
morbidity in 2006. Cost differences
between groups were nonsignificant
in 2006–2007, P> .50; cost differences
between groups in 2008 and 2009
were significant, P< .02, as tested by
general linear model.
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administrative expenses that include human resources, legal,
accounting, and administrative services) this constitutes a
fully burdened (conservative) ROI analysis.
In order to test whether or not participants dropped out
when they became sick, 2 cohorts with 5 years of claims data
were compared. The first 3 years were used as baseline data
for matching purposes. Year 4 was the participation year.
Year 5 was the year that differentiated the 2 groups into
participants who dropped out after taking the program, and
participants who were still in the program in Year 5.
Propensity score matching was used to match the 2 groups
on sex, age, morbidity in the previous 3 years (Year 1–Year
3), and total cost in the previous 3 years (Year 1–Year 3). Sex,
age, and morbidity in the previous 3 years also were used as
covariates in the model. When 2005 was the participation
year, there was not a significant difference in medical costs
between the 2 groups in 2006 (P = .367). This same nonsig-
nificant difference was found when the participation year
was 2006 (P = .807), 2007 (P = .260), and 2008 (P = .930). These
findings suggest there was no significant difference between
participants who dropped out versus those who remained in
the wellness program.
In addition to health care claim costs, health-related produc-
tivity cost savings is well established36–37 as an important
component of ROI analyses. Although information on produc-
tivity was obtained from program participants, this information
was not available for nonparticipants and comparative analy-
ses could not be performed on health-related productivity cost
savings. The health plan-focused nature of this project directed
attention more closely to claims-related costs.
Finally, one last question posed was whether there was a
relationship between cost, utilization, and degree of program en-
gagement. There was a strong linear association between the
number of program participation years and total health care
costs, regardless of whether total costs across all members or
total costs for a subcohort who had incurred 2009 costs were
FIG. 3. 2009 total member care
costs by number of years using the
program. Note: Health care costs
include inpatient, outpatient, med-
ical, and pharmacy costs. Members
who had conflicting sex in multiple
data sets, who reported being
pregnant, or more than 365 total
inpatient days in any 1 year were
excluded. Savings were adjusted for
sex, age, and morbidity in 2002, and
total health care cost in 2002. The
2009 health care costs were signifi-
cantly different by number of par-
ticipation year, F(8, 172903) = 8.92,
P < .0001.
FIG. 4. 2009 total member care
costs by number of years using the
program, among members with
2009 costs > $0. Note: Health care
costs include inpatient, outpatient,
medical, and pharmacy costs. Data
were derived from members with
2009 total health care costs > 0.
Members who had conflicting sex
in multiple data sets, who reported
being pregnant, or more than 365
total inpatient days in any 1 year
were excluded. Savings were ad-
justed for sex, age, morbidity in
2002, and total health care cost in
2002. The 2009 health care costs
were significantly different by
number of participation year, F(8,
159993) = 11.52, P < .0001.
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used in the analyses. The ROI value becomes more pro-
nounced with higher levels of baseline morbidity.
This study, like all studies, has some notable limitations.
First, the study was a retrospective cohort analysis without
the benefit of random assignment to the treatment/com-
parison groups or even an a priori set of questions or hy-
potheses from the outset of data collection. As such, selection
bias remains a primary potential threat to internal validity.
Participants and nonparticipants did differ significantly on
several key demographic variables that are worthy of
methodological control, but these same constructs also may
have implications for future program development and re-
cruitment. However, in order to better equate groups, the
research team matched cohorts statistically using propensity
score matching25–28 and further controlled group differences
with covariate statistical adjustment. Because this analysis is
taking into account the inherent self-selection bias in non-
randomized participation in wellness programs, the research
team believes that it represents a rigorous, albeit imperfect
test of ROI given the limitations of this retrospective meth-
odology.
Another limitation is a lack of specific health plan product
data for each individual throughout the 8-year time period.
Therefore, analyses regarding the impact of shifting among
plan designs, differences in plan payments, and members’
out-of-pocket payments for the different health plan types
could not be performed. There is also a relative paucity of
non-claims-related data (ie, behavioral, psychographic) for
the nonparticipants. In particular, the lack of psychographic
and behavioral data limits the ability to detail how the 2
samples may have differed in terms of psychological, atti-
tudinal, or behavioral constructs that are known to mediate
health behavior, risk profiles, utilization, and claims pat-
terns. In addition, biometric data were not collected from
nonparticipants, so it was not possible to analyze the impact
of program participation on potential biometric changes.
Finally, this study suffers from the ‘‘black box’’ problem in
that one cannot attribute change to any specific program
element, nor can one assure that the program was consis-
tently applied within or across the years represented in this
article. There are ways to address these problems in pro-
spective studies where methodological approaches such as
dismantling or statistical approaches such as structural
equation modeling can tease apart the relative strength of the
program’s ‘‘active ingredients.’’ However, these methods
likely would provide little information on sustainability.
FIG. 5. 2009 health care costs (among members with 2009 costs > $0) on 2009 morbidity and number of years of wellness
program participation. Note: Health care costs include inpatient, outpatient, medical, and pharmacy costs. Data were derived
from members with 2009 total health care costs > 0. Members who had conflicting sex in multiple data sets, who reported
being pregnant, or more than 365 total inpatient days in any 1 year were excluded. Savings were adjusted for sex, age,
morbidity in 2002, and total health care cost in 2002. The 2009 health care costs were significantly different by number of
participation year (F(8, 159912) = 2.67, P = .006), by 2009 morbidity levels (F(5, 159912) = 1411.36, P < .0001), and by the in-
teraction of number of participation year and 2009 morbidity levels (F(40, 159912) = 3.41, P < .0001).
Table 7. 2009 Health Care Costs by Morbidity Level and Degree of Prior Program Engagement
Number of Years Using Wellness Program
2009 Morbidity Yr 0 Yr 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr 6 Yr 7 Yr 8
0 $12 $12 $13 $14 $9 $8 $32 $122 $57
1 $129 $166 $185 $172 $197 $220 $201 $220 $288
2 $714 $767 $802 $784 $871 $814 $831 $753 $805
3 $1666 $1705 $1641 $1656 $1471 $1758 $1559 $1529 $1311
4 $2750 $2902 $2778 $2477 $2486 $2265 $2109 $1962 $2178
5 $4659 $4577 $3569 $3605 $3418 $3417 $3285 $3025 $2966
SUSTAINED VALUE OF WELLNESS AND DISEASE PREVENTION 97
Traditional randomized controlled trial methods are expen-
sive and impractical for comprehensive outcomes study.
Program evaluation methods38 that start with functional lo-
gic maps, such as the one used here, coupled with sophisti-
cated model building analytical tools are perhaps better
suited to this task.
Despite these challenges and the documented variability
in methodologies and analytical approaches in the literature,
an evidence base continues to build with the general trend
suggesting that when properly promoted and implemented,
such population health-focused programming can result in
both clinical and economic value. However, several signifi-
cant and related challenges face population health manage-
ment programming. The first is the magnitude of the
problem. Health care faces an aging population, followed by
a youth increasingly at risk for morbid obesity and all that
entails, both biologically and behaviorally. Second is the
relevance of behavior and behavior change technologies for
optimizing health and well-being. Much of the developing
risk is driven by modifiable psychological and behavioral
habits that center largely on activity, diet, and varying forms
of psychological distress. Unfortunately, traditional ap-
proaches to providing intervention to modify behavior and
lifestyle do not scale sufficiently (there is a paucity of avail-
able expertise and resources at all levels of care to meet the
demand). The challenge of scalability is the delivery of high-
quality services to address the range of behavioral habits,
problems, and attitudes in the service of health and well-
being. Face-to-face and telephonic services will always have
a place in the continuum of care but, given the growing
demand, new and novel methods of service delivery must be
developed that are economically sustainable and that ad-
dress the needs of the most people possible.
High technologies in the form of Web interventions, tele-
medicine, mobile messaging, online health information, and
mobile telemetry among others, have been cited as potential
solutions to the challenges of both scale and sustainability.39
They are occasionally offered as freestanding interventions
but more often coupled with other services (eg, face-to-face
counseling, home visits, telephonic support) and are part of a
continuum of care approach. Such technology, thoughtfully
applied, can foster greater participation in self-care across the
health spectrum as the industry moves toward a patient-
centered model of care. What remains to be seen is how best
to use these mediums to deliver content that represents a
true intervention as opposed to simply providing, via a novel
medium, the same old health information and content that
has been demonstrated to be necessary but insufficient to
change health behavior.
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